Clinical Trial Record

Return to Clinical Trials

Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer


2018-08-30


2020-09-24


2020-09-24


0

Study Overview

Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer

This trial studies nutritional preferences and product accessibility in oral nutritional supplements in participants with breast, colorectal, upper gastrointestinal, or prostate cancer. Learning what participants like and dislike about their current or past used nutritional supplements may help doctor know how to improve them.

PRIMARY OBJECTIVES: I. Identify how patients with cancer are obtaining nutrition to support medical management. SECONDARY OBJECTIVES: I. Examine associations of gastrointestinal side effects with specific diagnoses and respective medical therapies. II. Understand how patients access information regarding nutritional supplements. III. Evaluate patient satisfaction with currently available oral nutritional supplements (ONS). IV. Identify patient preferences in formulating a novel nutritional supplement. OUTLINE: Participants attend an interview over 15 minutes and complete surveys.

  • Breast Carcinoma
  • Cholangiocarcinoma
  • Colorectal Carcinoma
  • Gastric Carcinoma
  • Malignant Digestive System Neoplasm
  • Pancreatic Carcinoma
  • Prostate Carcinoma
  • OTHER: Interview
  • OTHER: Survey Administration
  • 0S-17-4
  • NCI-2018-00948 (REGISTRY Identifier) (REGISTRY: CTRP (Clinical Trial Reporting Program))
  • 0S-17-4 (OTHER Identifier) (OTHER: USC / Norris Comprehensive Cancer Center)
  • P30CA014089 (U.S. NIH Grant/Contract)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2018-06-08  

N/A  

2020-12-10  

2018-06-08  

N/A  

2020-12-14  

2018-06-20  

N/A  

2020-12  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A


Allocation:
N/A


Interventional Model:
N/A


Masking:
N/A


Arms and Interventions

Participant Group/ArmIntervention/Treatment
: Observational (interview, survey)

Participants attend an interview over 15 minutes and complete surveys.

OTHER: Interview

  • Attend an interview

OTHER: Survey Administration

  • Ancillary studies
Primary Outcome MeasuresMeasure DescriptionTime Frame
The way patients with cancer choose and obtain nutritional supplements to support medical managementData from the oral nutritional supplement survey that examines quality, quantity, access and affordability of oral nutrional supplements will be summarized.Up to 1 year
Secondary Outcome MeasuresMeasure DescriptionTime Frame
Associations of gastrointestinal side effects with specific diagnoses and respective medical therapiesData from the survey will be used for testing the association of gastrointestinal side effects with specific diagnosis and medical therapies.Up to 1 year

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Ability to comprehend English (both reading and writing)
  • Subjects in the inpatient and outpatient setting with the diagnosis of breast cancer, colorectal cancer, upper gastrointestinal cancer (including gastric, pancreatic, and cholangiocarcinoma), or prostate cancer
  • Receiving chemotherapy, biologic, or hormonal therapy in the University of Southern California (USC) Norris Comprehensive Cancer Center Day Hospital
  • Ability to understand and the willingness to sign a written informed consent

  • Exclusion Criteria:

  • Patients with a mental disability that makes them unable to understand and respond to the questions
  • Patients with reported non-oncologic associated deficits in taste and smell

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

  • National Cancer Institute (NCI)

  • PRINCIPAL_INVESTIGATOR: Jacek Pinski, MD, University of Southern California

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available